Crux Biomedical's Series B Round

Crux Biomedical raised a round of funding on January 09, 2009.

Crux Biomedical is focused on developing improved therapies for the human vasculature. The company's inferior vena cava filters (IVCF) are designed to prevent an often fatal condition known as pulmona…

Articles about Crux Biomedical's Series B Round: